AI Verdict
LIVE has stronger fundamentals based on our AI analysis.
LIVE vs LIPO Fundamental Comparison
| Metric | LIVE | LIPO |
|---|---|---|
| Revenue | $108.5M | $216,117.0 |
| Net Income | $-64,000.0 | $-3.9M |
| Net Margin | -0.1% | -1,799.1% |
| ROE | -0.1% | -261.4% |
| ROA | 0.0% | -165.5% |
| Current Ratio | 1.68x | 3.24x |
| Debt/Equity | 0.93x | 0.00x |
| EPS | $-0.02 | $-1.07 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
LIVE vs LIPO: Frequently Asked Questions
Is LIVE or LIPO a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), LIVE has stronger fundamentals. LIVE is rated SELL (72% confidence) while LIPO is rated STRONG SELL (90% confidence). This is not investment advice.
How does LIVE compare to LIPO fundamentally?
LIVE VENTURES Inc has ROE of -0.1% vs LIPELLA PHARMACEUTICALS INC.'s -261.4%. Net margins are -0.1% vs -1,799.1% respectively.
Which stock pays higher dividends, LIVE or LIPO?
LIVE has a dividend yield of N/A or no dividend while LIPO has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in LIVE or LIPO for long term?
For long-term investing, consider that LIVE has SELL rating with 72% confidence, while LIPO has STRONG SELL rating with 90% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about LIVE vs LIPO?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For LIVE vs LIPO, the AI consensus favors LIVE based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.